World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02556242
Date of registration: 07/09/2015
Prospective Registration: Yes
Primary sponsor: London School of Hygiene and Tropical Medicine
Public title: Targeted Indoor Residual Spraying Against Malaria TIRS
Scientific title: From Malaria Control to Sustainable Elimination: Cluster Randomised Trial Comparing Targeted Versus Generalised Vector Control in South Africa
Date of first enrolment: October 2015
Target sample size: 393387
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02556242
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
South Africa
Contacts
Name:     Immo Kleinschmidt, Phd
Address: 
Telephone:
Email:
Affiliation:  London School of Hygiene and Tropical Medicine
Name:     Maureen Coetzee, Phd
Address: 
Telephone:
Email:
Affiliation:  University of Witwatersrand, South Africa
Key inclusion & exclusion criteria

Inclusion criteria

1. Entire communities of approximately 8000 persons

2. Residents in malaria endemic districts of Limpopo and Mpumalanga Province

3. Areas with local malaria incidence <5 cases per 1000 per year on average over 5 years



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Intervention(s)
Other: Generalised Indoor residual spraying
Other: Targeted indoor residual spraying
Primary Outcome(s)
Malaria incidence, by routine passive case detection, of clinical malaria (fever =37.5°C, or history of fever (48 hours), in the presence of parasitaemia confirmed by RDT or microscopy). [Time Frame: Communities will be followed for up to 20 months]
Secondary Outcome(s)
If unsprayed, proportions due to refusals, spray teams not making contact and spray teams not calling back [Time Frame: By cross sectional household survey after 18 months]
Householder acceptability of IRS [Time Frame: By cross sectional household survey after 18 months]
Proportion of structures targeted for IRS unsprayed [Time Frame: Up to 20 months whenever reactive spraying is triggered]
Intervention costs per 1,000 households and cost-effectiveness of reactive, targeted indoor residual spraying (TIRS) compared to generalised IRS (GIRS) [Time Frame: Up to 20 months]
Sero-prevalence of antibodies to malaria antigens AMA-1 and MSP-1-19 [Time Frame: By cross sectional household survey after 18 months]
Household compliance (not painting, washing, re-plastering ) [Time Frame: By cross sectional household survey after 18 months]
Secondary ID(s)
EPIDZC8610
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Witwatersrand, South Africa
Medical Research Council
National Department of Health, South Africa
National Institute for Communicable Diseases, South Africa
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history